Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3692832010 | Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692834011 | Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Product containing only betamethasone and neomycin in ocular dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Betamethasone+neomycin sulfate (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Miscellaneous eye preparations (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Betamethasone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Adrenal hormone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Product containing neomycin in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Product containing betamethasone in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Betamethasone sodium phosphate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Corticosterone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Neomycin sulfate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Skin anti-infective (substance) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Adrenal hormone agent (substance) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Glucocorticoid hormone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a pour principe actif (attribut) | Local anti-infective (substance) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Product containing betamethasone in ophthalmic dosage form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Product containing neomycin in ophthalmic dosage form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage oculaire (forme pharmaceutique) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | a une forme pharmaceutique (attribut) | pommade ophtalmique | true | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | est un(e) (attribut) | Product containing betamethasone and neomycin (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator value (attribute) | cinq | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator value (attribute) | un | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has precise active ingredient | Betamethasone sodium phosphate | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has precise active ingredient | Neomycin sulfate | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has basis of strength substance (attribute) | Betamethasone sodium phosphate | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has basis of strength substance (attribute) | Neomycin sulfate | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)